Garde Capital’s Celgene Corp CELG Stock Holding History

Garde Capital’s Portfolio CELG Stock Details CELG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1,740	Closed	-$201K	–	119
2016 Q4	$201K	Buy	+1,740	New	+$194K	0.06%	116

Other funds holding CELG

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Garde Capital's CELG Position: Q1 2017 in Review

Garde Capital sold out of Celgene Corp (CELG) in Q1 2017, closing a stake of 1,740 shares — an estimated $201K sold.

Garde Capital first reported a position in CELG in Q4 2016 and held it in 1 quarter. The position peaked at $201K in Q4 2016. 1,417 funds tracked by Wall St. Rank hold CELG as of Q1 2017.

Garde Capital reported no remaining Celgene Corp position as of Q1 2017 after selling out during the quarter.
Garde Capital sold 1,740 Celgene Corp shares in Q1 2017, an estimated $201K.
Garde Capital first reported a position in Celgene Corp in Q4 2016 and held it in 1 quarter.
Garde Capital's Celgene Corp position peaked at $201K in Q4 2016.
1,417 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2017.

Based on Garde Capital's 13F filing for Q1 2017, filed 18 May 2017.